|
|
Volumn 25, Issue 6, 2007, Pages
|
|
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma [14]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
CHOP PROTOCOL;
MONOCLONAL ANTIBODY;
UNCLASSIFIED DRUG;
ADD ON THERAPY;
BACTERIAL INFECTION;
BLOOD TOXICITY;
BONE MARROW TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CD4+ T LYMPHOCYTE;
CLINICAL TRIAL;
DRUG RESPONSE;
HIV ASSOCIATED NONHODGKIN LYMPHOMA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LYMPHOCYTE COUNT;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
B CELL LYMPHOMA;
DISEASE FREE SURVIVAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
MALE;
MORTALITY;
NOTE;
PHASE 2 CLINICAL TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LYMPHOMA, AIDS-RELATED;
LYMPHOMA, NON-HODGKIN;
MALE;
PREDNISONE;
PROGNOSIS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VINCRISTINE;
|
|
EID: 33947572986
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.09.0407 Document Type: Letter |
|
Times cited : (5)
|
|
References (3)
|
